细胞角蛋白19片段与抗MDA5抗体阳性皮肌炎间质性肺病严重程度及不良预后相关
该回顾性研究纳入73例抗MDA5抗体阳性皮肌炎合并间质性肺病(MDA5-DM-ILD)患者,比较急性/亚急性间质性肺炎(A/SIP)与慢性间质性肺炎(CIP)的临床特征。结果显示A/SIP组血清CYFRA21-1更高(P=0.009),死亡者CYFRA21-1高于存活者(P<0.001),且CYFRA21-1与A/SIP发生及高死亡率相关。
要点
- MDA5-DM-ILD中A/SIP患者血清CYFRA21-1显著高于CIP患者(P=0.009)。
- 死亡患者CYFRA21-1水平高于存活者(P<0.001),且与更高死亡率相关(log-rank P<0.001)。
- 高CYFRA21-1、低氧合指数及较低区域实变与A/SIP风险升高相关。
核心结论
- CYFRA21-1可能是与MDA5-DM-ILD发生A/SIP相关的有用血清指标。
- CYFRA21-1与MDA5-DM-ILD患者不良生存相关。
研究设计与样本
- 回顾性分析73例MDA5-DM-ILD患者,比较A/SIP与CIP组的临床表现、实验室检查、外周血淋巴细胞亚群及肺功能。
主要发现
- 73例中26例表现为A/SIP模式。
- A/SIP组血清CYFRA21-1高于CIP组(P=0.009)。
- A/SIP组氧合指数、CD3+CD4+T细胞计数及CD3+CD4+细胞百分比低于CIP组。
- 38例死亡者CYFRA21-1水平高于35例存活者(P<0.001)。
- CYFRA21-1是预后因素并与更高死亡率相关(log-rank检验,P<0.001)。
临床怎么用
- 在MDA5-DM-ILD患者中可检测血清CYFRA21-1,辅助评估A/SIP发生风险及预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In the present study, we aimed to assess the clinical significance of cytokeratin 19 fragment (CYFRA21-1) in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive DM-interstitial lung disease (MDA5-DM-ILD). METHODS: A total of 73 MDA5-DM-ILD patients were retrospectively analysed in this work. Their clinical characteristics, including clinical manifestations, laboratory findings, peripheral blood lymphocyte subsets and lung function, were compared between patients with acute/subacute interstitial pneumonia (A/SIP) and chronic interstitial pneumonia (CIP). The level of serum CYFRA21-1 was also compared between the above-mentioned two groups of patients, and its association with the clinical features and mortality of MDA5-DM-ILD was also evaluated. RESULTS: Of the 73 MDA5-DM-ILD patients, 26 patients exhibited the A/SIP pattern. The level of serum CYFRA21-1 was higher in MDA5-DM patients with A/SIP compared with the CIP group (P = 0.009). Lower oxygenation index (OI), CD3+CD4+ T cell counts and percentage of CD3+CD4+ cells were also observed in MDA5-DM patients with A/SIP compared with the CIP group. Higher serum CYFRA21-1, lower OI, and lower zone consolidation were associated with a higher risk of A/SIP in MDA5-DM-ILD. In addition, 38 decedents with MDA5-DM-ILD exhibited a greater level of CYFRA21-1 compared with 35 survivors (P < 0.001). Furthermore, it was a prognostic factor and also associated with a higher mortality rate (log-rank test, P < 0.001). CONCLUSIONS: CYFRA21-1 could be a useful serum indicator associated with occurrence of A/SIP in MDA5-DM-ILD. Moreover, it was associated with a poor survival in MDA5-DM-ILD patients.
引用
- Gui X, Ma M, Ding J, et al. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2021. PMID: 33501503. doi:10.1093/rheumatology/keaa843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。